US equities
|
AAPL
$338.32
▲+0.00%
MU
$833.59
▲+0.00%
SNDK
$1,075.08
▲+0.00%
GOOGL
$278.99
▲+0.00%
PLTR
$178.34
▲+0.00%
NVDA
$202.06
▲+0.00%
INTC
$59.97
▲+0.00%
SPCX
$136.37
▲+0.00%
AAPL
$338.32
▲+0.00%
MU
$833.59
▲+0.00%
SNDK
$1,075.08
▲+0.00%
GOOGL
$278.99
▲+0.00%
PLTR
$178.34
▲+0.00%
NVDA
$202.06
▲+0.00%
INTC
$59.97
▲+0.00%
SPCX
$136.37
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Fangzhou Inc.
Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health
October 30, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices
October 27, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Showcases Award-Winning AI Chronic Care Solution at Fortune China 500 Forum
October 22, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou and Cutia Therapeutics Partner to Advance AI-Powered Dermatology and Chronic Health Management
October 19, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner
September 25, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou’s AI-Powered Chronic Care Model Named to Fortune China’s Best Designs 2026
September 03, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum
August 27, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
July 19, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care
July 09, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
June 05, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Ranked among 2025 Guangzhou AI Innovation “Most Promising Enterprises” for AI‑Powered Chronic Disease Services
May 18, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care
May 13, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
May 13, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026
April 27, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Inc. Appoints Healthcare Industry Veteran Wang Haijiao as Chief Executive Officer Following a Year of Record Growth and Profitability
March 26, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Reports Robust 2025 Financial Results, Boosted by AI Chronic Care Strategy
March 19, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services
February 28, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou’s MaaS Platform Recognized as Industry Leader at Guangdong Digital Economy Conference
February 10, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou ’XingShi’ Large Language Model Highlighted Among China’s Most Anticipated Healthcare Models for 2026
February 09, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Wins Tencent Health ‘AI-Powered Future Award’ as MaaS Platform Drives AI Chronic Care
February 08, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
January 26, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
January 26, 2026
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management
November 27, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Awarded “Golden Bull Award” for Leadership in AI-Powered Chronic Disease Management
November 08, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
November 07, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou’s “XingJie” LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations
November 02, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
October 29, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing
October 22, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
September 26, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025
September 17, 2025
From
Fangzhou Inc.
Via
GlobeNewswire
